Pfiz­er's Hos­pi­ra is­sues a re­call for a batch of propo­fol due to a vis­i­ble par­tic­u­late

Pfiz­er’s Hos­pi­ra, plagued by qual­i­ty con­trol prob­lems at mul­ti­ple plants over the years, is once again find­ing it­self vol­un­tar­i­ly re­call­ing one lot of Propo­fol In­jectable Emul­sion, USP 100 mL avail­able for sin­gle pa­tient use in a glass flip-top vial.

The batch is be­ing pulled due to a vis­i­ble par­tic­u­late ob­served in a sin­gle vial dur­ing an an­nu­al ex­am­i­na­tion of re­tained sam­ples. The re­call is be­ing con­duct­ed with the FDA’s knowl­edge, with a re­call let­ter is­sued by the com­pa­ny on Wednes­day and post­ed by the FDA.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER